Aneeka Mikael Hancock - Related publications

Affiliations: 
University of California, Irvine, Irvine, CA 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Sharma A, Müller J, Schuetze K, Rolfes V, Bissinger R, Rosero N, Ahmad A, Franklin BS, Zur B, Fröhlich H, Lang F, Oldenburg J, Pötzsch B, Wüllner U. Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology. 10. PMID 34439949 DOI: 10.3390/biology10080716   
2021 Cai HY, Fu XX, Jiang H, Han S. Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease. Npj Parkinson's Disease. 7: 91. PMID 34625569 DOI: 10.1038/s41531-021-00233-3   
2021 Cai P, Zheng Y, Sun Y, Zhang C, Zhang Q, Liu Q. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems. Acs Chemical Neuroscience. PMID 34623131 DOI: 10.1021/acschemneuro.1c00118   
2021 Sevgi F, Brauchle EM, Carvajal Berrio DA, Schenke-Layland K, Casadei N, Salker MS, Riess O, Singh Y. Imaging of α-Synuclein Aggregates in a Rat Model of Parkinson's Disease Using Raman Microspectroscopy. Frontiers in Cell and Developmental Biology. 9: 664365. PMID 34568310 DOI: 10.3389/fcell.2021.664365   
2021 Ma YF, Lin YA, Huang CL, Hsu CC, Wang S, Yeh SR, Tsai YC. Lactiplantibacillus plantarum PS128 Alleviates Exaggerated Cortical Beta Oscillations and Motor Deficits in the 6-Hydroxydopamine Rat Model of Parkinson's Disease. Probiotics and Antimicrobial Proteins. PMID 34449056 DOI: 10.1007/s12602-021-09828-x   
2021 Guo YJ, Xiong H, Chen K, Zou JJ, Lei P. Brain regions susceptible to alpha-synuclein spreading. Molecular Psychiatry. PMID 34561613 DOI: 10.1038/s41380-021-01296-7   
2021 Mitkova Z, Kamusheva M, Kalpachka D, Ignatova D, Tachkov K, Petrova G. Review of medicine utilization for Parkinson's disease management: the Bulgarian perspective. Journal of Public Health Research. PMID 34351100 DOI: 10.4081/jphr.2021.2396   
2021 Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, Blandini F, Cerri S. Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease. International Journal of Molecular Sciences. 22. PMID 34445626 DOI: 10.3390/ijms22168920   
2021 Mottaghi S, Kohl S, Biemann D, Liebana S, Montaño Crespo RE, Buchholz O, Wilson M, Klaus C, Uchenik M, Münkel C, Schmidt R, Hofmann UG. Bilateral Intracranial Beta Activity During Forced and Spontaneous Movements in a 6-OHDA Hemi-PD Rat Model. Frontiers in Neuroscience. 15: 700672. PMID 34456673 DOI: 10.3389/fnins.2021.700672   
2021 Mirzaei S, Kulkarni K, Zhou K, Crack PJ, Aguilar MI, Finkelstein DI, Forsythe JS. Biomaterial Strategies for Restorative Therapies in Parkinson's Disease. Acs Chemical Neuroscience. PMID 34634903 DOI: 10.1021/acschemneuro.1c00484   
2021 Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451872 DOI: 10.3390/ph14080775   
2021 Kang B, Li N, Liu S, Qi S, Mu S. Protective Effect of Isopulegol in Alleviating Neuroinflammation in Lipopolysaccharide-Induced BV-2 Cells and in Parkinson Disease Model Induced with MPTP. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 40: 75-85. PMID 34587406 DOI: 10.1615/JEnvironPatholToxicolOncol.2021038944   
2021 Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula KR, Kukle P, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors. Journal of Personalized Medicine. 11. PMID 34357147 DOI: 10.3390/jpm11070680   
2021 Hill AE, Wade-Martins R, Burnet PWJ. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Frontiers in Neuroscience. 15: 708587. PMID 34512244 DOI: 10.3389/fnins.2021.708587   
2021 Christmann A, Gries M, Scholz P, Stahr PL, Law JKY, Schulte S, Martin M, Lilischkis R, Ingebrandt S, Keck CM, Schäfer KH. The antioxidant Rutin counteracts the pathological impact of -synuclein on the enteric nervous system . Biological Chemistry. PMID 34582634 DOI: 10.1515/hsz-2021-0259   
2021 Ren C, Wang F, He KJ, Zhang YT, Li LX, Zhang JB, Chen J, Mao CJ, Liu CF. Early-life stress induces prodromal features of Parkinsonian with aging in rats. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34448826 DOI: 10.1093/gerona/glab253   
2021 Ishikuro K, Hattori N, Imanishi R, Furuya K, Nakata T, Dougu N, Yamamoto M, Konishi H, Nukui T, Hayashi T, Anada R, Matsuda N, Hirosawa H, Tanaka R, Shibata T, et al. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report. Neurocase. 1-8. PMID 34503372 DOI: 10.1080/13554794.2021.1975768   
2021 Nam MH, Park JH, Song HJ, Choi JW, Kim S, Jang BK, Yoon HH, Heo JY, Lee H, An H, Kim HJ, Park SJ, Cho DW, Yang YS, Han SC, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34611843 DOI: 10.1007/s13311-021-01097-4   
2021 Kwon SH, Kim S, Park AY, Lee S, Gadhe CG, Seo BA, Park JS, Jo S, Oh Y, Kweon SH, Ma SX, Kim WR, Kim M, Kim H, Kim JE, et al. A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease. Journal of Medicinal Chemistry. PMID 34583507 DOI: 10.1021/acs.jmedchem.1c01022   
2021 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-B pathway through microbiota-gut-brain axis. Acta Pharmaceutica Sinica. B. 11: 2859-2879. PMID 34589401 DOI: 10.1016/j.apsb.2021.03.020   
2021 Hsu YL, Hung HS, Tsai CW, Liu SP, Chiang YT, Kuo YH, Shyu WC, Lin SZ, Fu RH. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro. International Journal of Molecular Sciences. 22. PMID 34638579 DOI: 10.3390/ijms221910240   
2021 Xu Y, Surface M, Chan AK, Halpern J, Vanegas-Arroyave N, Ford B, Feeney MP, Kwei KT, Katus LE, Kuo SH, Shah H, Waters C, Winfield LM, Beck JC, Przedborski S, et al. COVID-19 manifestations in people with Parkinson's disease: a USA cohort. Journal of Neurology. PMID 34482434 DOI: 10.1007/s00415-021-10784-3   
2021 Kitzmann S, Hartmann K, Zablotski Y, Rieger A, Mueller R, Wehner A. Wellbeing, quality of life, presence of concurrent diseases, and survival times in untreated and treated German Shepherd dogs with dwarfism. Plos One. 16: e0255678. PMID 34370756 DOI: 10.1371/journal.pone.0255678   
2021 Pottenger AE, Bartlett MJ, Sherman SJ, Falk T, Morrison HW. Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment. Neuroscience Letters. 136251. PMID 34536508 DOI: 10.1016/j.neulet.2021.136251   
2021 Sakurai A, Tsunemi T, Ishiguro Y, Okuzumi A, Hatano T, Hattori N. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. Journal of Neurology. PMID 34468800 DOI: 10.1007/s00415-021-10778-1   
2021 Wijesekara N, Ahrens R, Wu L, Langman T, Tandon A, Fraser PE. α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport. Frontiers in Aging Neuroscience. 13: 665348. PMID 34393754 DOI: 10.3389/fnagi.2021.665348   
2021 Arkan S, Ljungberg M, Kirik D, Hansen C. DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease. Neurobiology of Disease. 158: 105477. PMID 34390836 DOI: 10.1016/j.nbd.2021.105477   
2021 Evans LE, Taylor JL, Smith CJ, Pritchard HAT, Greenstein AS, Allan SM. Cardiovascular co-morbidities, inflammation and cerebral small vessel disease. Cardiovascular Research. PMID 34499123 DOI: 10.1093/cvr/cvab284   
2021 Leung D, Bonacorsi S, Smith RA, Weber W, Hayes W. Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic. Frontiers in Oncology. 11: 698425. PMID 34497758 DOI: 10.3389/fonc.2021.698425   
2021 Ye L, Sun Y, Jiang Z, Wang G. L-Serine, an Endogenous Amino Acid, Is a Potential Neuroprotective Agent for Neurological Disease and Injury. Frontiers in Molecular Neuroscience. 14: 726665. PMID 34552468 DOI: 10.3389/fnmol.2021.726665   
2021 Yan J, Liu A, Huang J, Wu J, Shen R, Ma H, Yang J. Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review. Frontiers in Aging Neuroscience. 13: 709878. PMID 34483882 DOI: 10.3389/fnagi.2021.709878   
2021 Sigurdsson HP, Raw R, Hunter H, Baker MR, Taylor JP, Rochester L, Yarnall AJ. Non-invasive vagus nerve stimulation in Parkinson's disease: current status and future prospects. Expert Review of Medical Devices. PMID 34461787 DOI: 10.1080/17434440.2021.1969913   
2021 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Neurochemical Features of Rem Sleep Behaviour Disorder. Journal of Personalized Medicine. 11. PMID 34575657 DOI: 10.3390/jpm11090880   
2021 Chetia Phukan B, Dutta A, Deb S, Saikia R, Mazumder MK, Paul R, Bhattacharya P, Sandhir R, Borah A. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response. Experimental Brain Research. PMID 34633467 DOI: 10.1007/s00221-021-06237-y   
2021 Iyer V, Venkiteswaran K, Savaliya S, Lieu CA, Handly E, Gilmour TP, Kunselman AR, Subramanian T. The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias. Neurobiology of Disease. 105491. PMID 34461264 DOI: 10.1016/j.nbd.2021.105491   
2021 Bantle CM, Rocha SM, French CT, Phillips AT, Tran K, Olson KE, Bass TA, Aboellail T, Smeyne RJ, Tjalkens RB. Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis. Experimental Neurology. 346: 113845. PMID 34454938 DOI: 10.1016/j.expneurol.2021.113845   
2021 Lilach S, Hagai B, Zvi I, Hermona S, Wael M. MicroRNA expression changes in Parkinson's disease (PD) patients' leukocytes prior to and following deep brain stimulation (DBS). American Journal of Neurodegenerative Disease. 10: 28-33. PMID 34327050   
2021 Burbulla LF, Zheng J, Song P, Jiang W, Johnson ME, Brundin P, Krainc D. Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease models. Jci Insight. 6. PMID 34622801 DOI: 10.1172/jci.insight.148649   
2021 Wong JK, Hilliard JD, Holanda VM, Gunduz A, Wagle Shukla A, Foote KD, Okun MS. Time for a New 3-D Image for Globus Pallidus Internus Deep Brain Stimulation Targeting and Programming. Journal of Parkinson's Disease. PMID 34420982 DOI: 10.3233/JPD-212820   
2021 Maillet A, Météreau E, Tremblay L, Favre E, Klinger H, Lhommée E, Le Bars D, Castrioto A, Prange S, Sgambato V, Broussolle E, Krack P, Thobois S. Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34494685 DOI: 10.1002/mds.28722   
2021 Becker G, Michel A, Bahri MA, Mairet-Coello G, Lemaire C, Deprez T, Freyssin A, Jacquin L, Hustadt F, De Wolf C, Caruso M, Frequin JM, Gillent E, Bezard E, Garraux G, et al. Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[F]fluoro-L-m-tyrosine imaging and motor performances analysis. Neurobiology of Aging. 107: 142-152. PMID 34433125 DOI: 10.1016/j.neurobiolaging.2021.07.012   
2021 Jenner P, Rocha JF, Ferreira JJ, Rascol O, Soares-da-Silva P. Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone. Expert Review of Neurotherapeutics. 21: 1019-1033. PMID 34525893 DOI: 10.1080/14737175.2021.1968298   
2021 Keerie A, Brown-Wright H, Kirkland I, Grierson A, Alix JJP, Holscher C, Mead RJ. The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1 and TDP-43 transgenic mouse models of ALS. Scientific Reports. 11: 17027. PMID 34426623 DOI: 10.1038/s41598-021-96418-0   
2021 Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biology. 47: 102134. PMID 34600334 DOI: 10.1016/j.redox.2021.102134   
2021 Theofilis P, Oikonomou E, Vogiatzi G, Antonopoulos AS, Siasos G, Iliopoulos DC, Perrea D, Tsioufis C, Tousoulis D. The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies. Vascular Pharmacology. 106906. PMID 34509635 DOI: 10.1016/j.vph.2021.106906   
2021 Rusch C, Beke M, Tucciarone L, Dixon K, Nieves C, Mai V, Stiep T, Tholanikunnel T, Ramirez-Zamora A, Hess CW, Langkamp-Henken B. Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson's disease (the MEDI-PD study): study protocol for a randomised controlled trial. Bmj Open. 11: e053336. PMID 34551955 DOI: 10.1136/bmjopen-2021-053336   
2021 Tamilanban T, Manasa K, Chitra V. In silico docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's disease and its In vivo Evaluation by Zebrafish Model. Cns & Neurological Disorders Drug Targets. PMID 34477539 DOI: 10.2174/1871527320666210903091447   
2021 Bian LH, Yao ZW, Zhao CB, Li QY, Shi JL, Guo JY. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor. Evidence-Based Complementary and Alternative Medicine : Ecam. 2021: 6686965. PMID 34426745 DOI: 10.1155/2021/6686965   
2021 Samotus O, Chen R, Jog M. Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy. Neurology. PMID 34497068 DOI: 10.1212/WNL.0000000000012662   
2021 Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. Journal of Parkinson's Disease. PMID 34602502 DOI: 10.3233/JPD-212876